Home » Stocks » Dare Bioscience

Dare Bioscience, Inc. (DARE)

Stock Price: $1.14 USD 0.03 (2.70%)
Updated Aug 3, 2020 4:00 PM EDT - Market closed
Pre-market: $1.17 +0.03 (2.63%) Aug 4, 7:02 AM

Stock Price Chart

Key Info

Market Cap 30.38M
Revenue (ttm) n/a
Net Income (ttm) -15.46M
Shares Out 26.65M
EPS (ttm) -0.87
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $1.14
Previous Close $1.11
Change ($) 0.03
Change (%) 2.70%
Day's Open 1.10
Day's Range 1.10 - 1.16
Day's Volume 398,798
52-Week Range 0.69 - 2.22

More Stats

Market Cap 30.38M
Enterprise Value 26.02M
Earnings Date (est) Aug 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 26.65M
Float 23.88M
EPS (basic) -0.88
EPS (diluted) -0.87
FCF / Share -0.70
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 263,105
Short Ratio 0.16
Short % of Float 1.04%
Beta 1.47
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 9.29
Revenue n/a
Operating Income -15.52M
Net Income -15.46M
Free Cash Flow -16.60M
Net Cash 4.36M
Net Cash / Share 0.16
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -127.31%
ROE -442.18%
ROIC 3,445.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.63*
(306.14% upside)
Low
3.00
Current: $1.14
High
7.52
Target: 4.63
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue-----0.080.010.63
Revenue Growth-----1233.33%-99.04%-
Gross Profit-----0.080.010.63
Operating Income-14.34-16.88-11.18-0.63-37.17-20.28-15.86-21.58
Net Income-14.26-16.74-11.50-0.67-39.59-23.34-17.14-22.10
Shares Outstanding15.5810.733.230.842.541.450.070.06
Earnings Per Share-0.97-1.57-3.56-0.81-15.60-16.00-250.50-363.90
Operating Cash Flow-13.32-10.27-2.54-0.37-31.92-19.06-16.61-21.01
Capital Expenditures--0.01---0.25-0.19-0.01-0.18
Free Cash Flow-13.32-10.28-2.54-0.37-32.17-19.25-16.62-21.19
Cash & Equivalents4.786.817.560.0475.9151.175.490.00
Total Debt0.800.01-0.7020.323.1215.08-
Net Cash / Debt3.986.807.56-0.6555.5848.05-9.590.00
Assets7.447.8314.260.0478.2353.396.83-
Liabilities7.001.100.970.7629.488.07101-
Book Value0.446.7313.29-0.7148.7445.33-94.30-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Dare Bioscience, Inc.
Country United States
Employees 15
CEO Sabrina Martucci Johnson

Stock Information

Ticker Symbol DARE
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: DARE

Description

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.